Sign In
Buy RMD
$188.63
+2.34 (+1.26%)
At Close: Jun 18, 2026
Silver Economy Investing: Why the Healthcare Giants Are in Focus
04:01pm, Tuesday, 19'th May 2026
Healthcare giants like Eli Lilly, Tandem Diabetes, Intuitive Surgical and ResMed are tapping aging-driven demand in obesity, surgery and sleep care.
Resmed and ŌURA Partner to Expand Access to Sleep Health Education and Care
09:00am, Tuesday, 19'th May 2026
SAN DIEGO, May 19, 2026 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing and care delivered in the home, and ŌURA, maker of the worl
A Look at ResMed Inc (RMD) After 3.9% Decline -- GF Value $270.01 vs Price $198.76
08:32pm, Monday, 11'th May 2026
On May 11, 2026, ResMed Inc (RMD) shares fell 3.9% to a current price of $198.76. This decline comes amid broader market pressures, with the stock now trading c
10 Dividend Growth Stocks: May 2025
09:00am, Saturday, 09'th May 2026
Dividend growth stocks have a streak of at least 5 consecutive years of dividend increases. I rank a selection of dividend growth stocks and present the top 10 stocks for consideration. To rank stocks
Here's Why ResMed (RMD) is a Strong Growth Stock
10:45am, Tuesday, 05'th May 2026
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
RMD Stock Down Despite Q3 Earnings & Revenue Beat, Margins Rise
09:05am, Friday, 01'st May 2026
Resmed beats Q3 earnings and revenue estimates with strong margin gains, yet shares slip post earnings despite growth across key segments.
ResMed Inc (RMD) Q3 2026 Earnings Call Highlights: Strong Revenue Growth and Strategic Acquisitions
02:18am, Friday, 01'st May 2026
Revenue: $1.43 billion, an 11% increase year-over-year, 8% in constant currency.Gross Margin: 62.8%, increased by 290 basis points year-over-year.Operating Mar
ResMed (RMD) Reports Q3 Earnings: What Key Metrics Have to Say
06:30pm, Thursday, 30'th Apr 2026
Although the revenue and EPS for ResMed (RMD) give a sense of how its business performed in the quarter ended March 2026, it might be worth considering how some key metrics compare with Wall Street es
ResMed (RMD) Surpasses Q3 Earnings and Revenue Estimates
06:30pm, Thursday, 30'th Apr 2026
ResMed (RMD) came out with quarterly earnings of $2.86 per share, beating the Zacks Consensus Estimate of $2.79 per share. This compares to earnings of $2.37 per share a year ago.
ResMed beats quarterly profit estimates, names new CFO
06:21pm, Thursday, 30'th Apr 2026
Medical device maker ResMed beat third‑quarter profit estimates on Thursday, driven by strong demand for its medical devices, while appointing Aaron Bloomer as its new chief financial officer.
Resmed Chief Financial Officer Brett Sandercock to Retire; Aaron Bloomer Appointed as Successor
04:10pm, Thursday, 30'th Apr 2026
SAN DIEGO, April 30, 2026 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing and care delivered in the home, today announced that Brett
Resmed Inc. Announces Results for the Third Quarter of Fiscal Year 2026
04:05pm, Thursday, 30'th Apr 2026
Revenue increased by 11% to $1.4 billion; up 8% on a constant currency basis GAAP gross margin up 290 bps to 62.2%; non-GAAP gross margin up 290 bps to 62.8% GAAP income from operations increased
Wall Street's Insights Into Key Metrics Ahead of ResMed (RMD) Q3 Earnings
10:15am, Wednesday, 29'th Apr 2026
Besides Wall Street's top-and-bottom-line estimates for ResMed (RMD), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quart
Arizona State Retirement System Trims Stock Position in ResMed Inc. $RMD
03:08am, Sunday, 26'th Apr 2026
Arizona State Retirement System cut its holdings in shares of ResMed Inc. (NYSE: RMD) by 7.6% during the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchang
ResMed (RMD) Reports Next Week: Wall Street Expects Earnings Growth
11:05am, Thursday, 23'rd Apr 2026
ResMed (RMD) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
